Healthcare

   By the end of 2022, the market for   varicose vein treatment market size   will be valued at US$ 716.5 million, up from US$ 671.5 million in 2021. In addition, due to the increasing frequency of varicose veins and increased public awareness of their different treatments, the market for varicose vein treatments is expected to reach a value of US$ 1.4 Bn by 2032, growing at a CAGR of 6.8% between 2022 and 2032. Along with this, the demand for varicose vein treatments is also expected to grow on the account of effectiveness of the treatments, utilisation of user-friendly devices, and growing emphasis of medical practitioners on ensuring patient safety during critical treatment of varicose veins. Towards the end of 2026, the global market for  varicose vein treatment  will have reached value of US$ 931.4 Mn, registering a robust growth at 6.4% CAGR. Unattended varicose veins can cause one severe pain through swelling, ulceration, venous eczema, and lipodermatosclerosis. Treating them t

  According to a recent market study by Future Market Insights (FMI), the global   infusion pumps market size   was estimated to be worth US$ 4.4 billion in 2022 and is projected to grow to US$ 6.6 billion by 2030. As per World Health Organization’s projections, there were 422 million diabetic people as of 2014, with a 5% increase in premature mortality. Consequently, there has also been an increase in associated co-morbidities such as strokes, heart attacks, kidney failure and visual impairment. As a result,  infusion pump  usage has upticked in order to provide the appropriate medication and nutritional input. To facilitate efficient drug delivery, manufacturers have incorporated various technological advancements in recent years. Additionally, the advent of wearable and smart infusion pumps is further fueling the market’s revenue prospects. Global Infusion Pumps Market- Key Takeaways Rising prevalence of cancer to push forward oncology-grade infusion pumps usage in the coming years

The global   clinical decision support market size  is likely to reach a valuation of  US$ 2.2 Billion  in 2022. However, Government recognition and initiatives to encourage the adoption of CDSS and EHR systems are estimated to further increase the demand for clinical decision support market is projected to grow at a robust CAGR of  8.2%  between 2022 and 2032, totaling around  US$ 4.9 Billion  by the end of 2032. The adoption of  clinical decision support  in the healthcare industry and surging investments in R&D, and innovations in clinical decision support systems increase the demand for the market. Leading clinical decision support system manufacturers are increasingly focusing on introducing novel compact and advanced clinical decision support systems this in turn is anticipated to foster the market growth in the near future. Also, the growing risk of data privacy and the lack of technically qualified and skilled staff to implement the CDSS and resolve related issues are some

  In 2022, it is anticipated that the   global automated sample storage systems market   will be worth US$ 992.5 million, rising to US$ 3,395.6 million in 2032. During the aforementioned time frame, a CAGR of 11.8% is forecast for the market. Automated Sample Storage Systems Market Treatment Market: Overview Automated sample storage systems has created a requirement for effective storage practices and standard operating procedures. The requirement of maintaining sample integrity and viability by adopting new storage methodologies and solutions assures better sample quality for the research community and thus proliferate the market of automated sample storage systems. Demand of these products is also increasing in the manufacturing industries for storing large scale industrial samples mostly in the biopharmaceutical and chemical industries. Vendors such as Biomatrica and IntegenX, Inc are also involved in developing reagents for stabilizing the DNA and RNA as to keep them last long unde

  The global  diabetic shoes market size   is expected to grow at  6.4% CAGR  during the forecast period of 2022-2032, opines Future Market Insights (FMI). Diabetic footwear  with distinct vital components such as raw material and comfort are becoming increasingly popular among diabetes patients worldwide. They help to reduce the risk of skin damage in diabetic patients with pre-existing diet issues. The overall demand in the market is driven by increased innovation by major players to offer personalized and attractive diabetic footwear to meet the latest fashion trends, particularly among the female population. The quality of life of diabetic patients have improved dramatically when they use diabetic shoes on a regular basis. Adoption of these shoes is also increasing as they are cost-effective with professional care services such as diabetic foot ulcer treatment and amputations. This aspect is expected to boost the diabetic footwear sales in the coming years. Further, increased deman

  Global  medical protective equipment market share  will experience a major upturn in 2022 and onwards, amid the global COVID-19 pandemic, reaching a projected valuation of over US$ 41 Bn through 2030. The growing pandemic of community infections owing to emergence of new pathogens is expected to increase the demand of  medical protective equipments  in the global market. This rising number of community and hospital acquired infections will drive market growth in the near future, says a new Future Market Insights (FMI) report. Key manufacturers operating in the  medical safety equipment  market offer a wide range of products such as medical masks, gloves, protective clothing, gowns and other products. Owing to non-availability of treatment for new pathogen infections and significant lag phase between the emergence of new pathogen and development of effective treatment, there has been an increasing demand for medical protective equipment, creating an absolute opportunity for growth of

  The global  drug screening market size  is projected to expand at a 16% CAGR from US$ 5.3 Bn in 2021 to US$ 18 Bn by 2032 showing an immense improvement. A crucial driver of the drug screening market is the overuse of prescribed drugs and the elevated use of narcotics. According to one of the recent World Drug Reports, drug and alcohol abuse and consumption are on the rise globally. Drug abuse killed nearly 500,000 people, while drug use disorders resulted in the loss of 18 million years of a healthy life, primarily due to opioids. Similar increases in alcohol consumption have been observed, with the consequences being an increase in the incidence of impaired driving. The rising consumption of illicit drugs and alcohol will accelerate the development of  drug screening  products and services on the road, fuelling the  drug screening market growth . Some countries, including South Africa, Colombia, Chile, Argentina, and Canada, consider workplace drug and alcohol testing to violate em

  In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI), the worldwide   peptide therapeutics market share   currently valued at US$ 34.4 billion, is anticipated to grow at a remarkable CAGR of 11% from 2022 to 2025, reaching US$ 47 billion. Peptide therapeutics demand are witnessing substantial demand, owing to increasing application in the treatment of various chronic disease such as cancer, cardiovascular diseases, hematologic diseases, and gastro-intestinal diseases. Rising prevalence of these chronic diseases across the world is further expected to widen the existing patient pool. Therapeutic efficacy of  peptide therapeutics  is relatively superior as compared to other marketed drugs, resulting in their higher adoption among physicians. The global peptide therapeutics market was valued at US$ 25.6 Bn in 2021, and is expected to exhibit a healthy CAGR of 11% during the forecast period (2022-2025). The COVID-19 pandemic has been severel

  Global  laboratory information system (LIS) market size   revenues are set to grow at 10.2% CAGR through 2030, according to an updated edition by Future Market Insights (FMI). The 2022-2030 version of the report builds upon the widely cited previous version, and incorporates the latest developments, notably, the impact of COVID-19 pandemic on this market. Massive technical improvements in the healthcare sector over time have included automation, big data analytics, and cloud computing. The necessity to balance administrative and caring activities is the most crucial factor in the sector. Thanks to the development of sophisticated laboratory testing technologies, this is now achievable. The cornerstone of managing primary healthcare is laboratories. Drug development and the creation of APIs take place in laboratories. It is necessary to streamline repetitive tasks like data collection, assimilation, and record maintenance in order to increase the speed at which these processes are eff